Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Lupin gets USFDA nod for Clobazam Oral Suspension

31 December, 2018 1:16 PM
65 0
Lupin gets USFDA nod for Clobazam Oral Suspension

Drug maker Lupin said it has received approval from the US health regulator for Clobazam Oral Suspension, used to treat seizures associated with Lennox-Gastaut Syndrome.

The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Lundbeck Pharmaceuticals LLC's Onfi Oral Suspension, Lupin said in a regulatory filing.

The drug is indicated for treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients of two years of age or older.

Source: moneycontrol.com

Share in social networks:

Comments - 0